Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Biotech pipeline by acquisition

Biotech pipeline by acquisition

The combination of American Cyanamid and American Home Products, beyond creating the world's fourth largest drug company, also will bring Immunex Corp. and Genetics Institute Inc. under the same umbrella.

American Home, which already owns more than 65 percent of Cambridge, Mass.-based GENIZ, will assume Cyanamid's majority stake in IMNX after the pharma merger, which

Read the full 584 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers